Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China.
School of Pharmacy, Yantai University, Yantai, China.
Drug Deliv. 2020 Dec;27(1):248-257. doi: 10.1080/10717544.2020.1716875.
Cancer is a kind of malignant diseases that threatens human health and the research application of anti-tumor drug therapeutics is growingly always been focused on. Many new compounds with great anticancer activity were synthesized but cannot be hard to be developed into clinical use due to its poor water solubility. Deoxypodophyllotoxin (DPT) is just an example. We develop lyophilized Deoxypodophyllotoxin (DPT) loaded polymeric micelles using methoxy polyethylene glycol-block-Poly (D, L-lactide) (mPEG-PLA). DPT-PM freeze-dried powder was successfully prepared using optimized formulation. mPEG-PLA was added to hydration media before hydrating as cryoprotectants. The freeze-dried powder exhibited white pie-solid without collapsing, and the particle size of DPT-PM reconstituted with water was about 20-35 nm. The entrapment efficiency of the reconstituted solution was 98%, which shows no differences with the micelles before lyophilization. cytotoxicity and cellular uptake studies showed that DPT-PM has a higher degree of cytotoxicity comparing with DPT and mPEG-PLA micelles and uptake of mPEG-PLA was concentration and time-dependent. In vivo characterization of DPT-PM was done for pharmacokinetics behaviors, antitumor activity and safety. The obtained results showed significant improvement in plasma clearance bioavailability ( <0.05) and prolonged blood circulation time comparing with DPT-HP-β-CD. Moreover, mPEG-PLA micelles had a better degree of anti-tumor efficacy, this was due to better accumulation of mPEG-PLA in tumor cell via enhanced permeability and retention (EPR) effect. Therefore, DPT-PM has great clinical value, and can be expected to be a novel antitumor preparation.
癌症是一种威胁人类健康的恶性疾病,抗肿瘤药物治疗的研究应用一直备受关注。许多具有很强抗癌活性的新化合物被合成,但由于其水溶性差,很难开发成临床应用。脱氧鬼臼毒素(DPT)就是一个例子。我们使用甲氧基聚乙二醇-聚(D,L-丙交酯)(mPEG-PLA)制备冻干的脱氧鬼臼毒素(DPT)载药聚合物胶束。采用优化的处方成功制备了 DPT-PM 冻干粉。在水化前,mPEG-PLA 作为冷冻保护剂加入到水化介质中。冻干粉末呈白色块状,无塌陷,水重溶后 DPT-PM 的粒径约为 20-35nm。包封率为 98%,与冻干前的胶束无差异。细胞毒性和细胞摄取研究表明,DPT-PM 比 DPT 和 mPEG-PLA 胶束具有更高的细胞毒性,且 mPEG-PLA 的摄取具有浓度和时间依赖性。对 DPT-PM 的体内特性进行了药代动力学行为、抗肿瘤活性和安全性研究。结果表明,与 DPT-HP-β-CD 相比,DPT-PM 的血浆清除率生物利用度显著提高(<0.05),血液循环时间延长。此外,mPEG-PLA 胶束具有更好的抗肿瘤疗效,这是由于通过增强渗透和滞留(EPR)效应,mPEG-PLA 更好地积聚在肿瘤细胞中。因此,DPT-PM 具有很大的临床价值,有望成为一种新型抗肿瘤制剂。